Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation.

Mojahidul Islam Jayesh Kumar Sevak Manoj Kumar Sharma Ankur Jindal Ashish Kumar Vyas Meenu Bajpai Gayatri Ramakrishna Shiv Kumar Sarin Nirupama Trehanpati

Published in: Alimentary pharmacology & therapeutics (2022)

Non-seroconverters have increased inhibitory markers on CD4/CD8 T cells. There is a critical play of CD8, Tfh and B cells and subsets in seroclearance, along with checkpoint molecules as a potential therapy for non-seroconverters in HBV infection.

Keyphrases

hepatitis b virus
dna damage
nk cells
cell cycle
peripheral blood
liver failure
oxidative stress
risk assessment
climate change